In a conventional way, miR-26a prevents obesity-induced hyperinsulinemia in endogenous β cells through two mechanisms: miR-26a reduces compensatory β cell hyperplasia by decreasing β cell replication stimulated by excess nutrition and inhibits excess insulin secretion in response to hyperglycemia by modulating actin remodeling. The gene discussed is INS; the disease is Hyperinsulinemia.